Keep up to Date with Latin American VC, Startups News
The global wellness and dietary supplement industry, valued at hundreds of billions of dollars, is a constantly evolving sector marked by scientific innovation and network dynamics. In this competitive landscape, growth strategies and strategic alliances often redefine the market map.
Immunotec, a company with a presence in 18 countries and recognized for its glutathione research, has announced a strategic move: the integration of the My Daily Choice (MDC) network. This multilevel marketing company, which reports having collected US$600 million in sales and more than one million members globally, is now merging with Immunotec’s operation.
The company recently recorded its best ever month in global sales. According to Mauricio Domenzain, CEO of the company, this historic record was possible thanks to the work of its consultants and this new integration, aligning with its strategic vision of long-term growth.
A year of milestones and expansion
The company’s growth during 2025 appears to have been underpinned by several pillars. The company reports unprecedented demand for its flagship product, Immunocal, a glutathione precursor. In parallel, it has implemented a series of incentives for its network of consultants, including exclusive events and a new wave of promotions in its rank structure.
The integration of MDC founder Josh Zwagil under ImmunotecPro represents a notable chapter in this expansion. Zwagil, who built one of the most dynamic communities in the industry, said his decision to join Immunotec was based on the credibility of its products and the strength of its community. He achieved Platinum status with the company in a record 15 days.
In a parallel promotion that reflects organic growth, Mexican leader Araceli Carrillo achieved Senior Platinum, the company’s most prestigious rank, after years of expanding the network in markets such as Mexico, Spain and Italy.
Science as a foundation
Beyond commercial dynamics, Immunotec focuses its value proposition on scientific validation. Its core product, Immunocal, is touted as one of the most clinically supported supplements globally, with more than 100 published studies and numerous patents.
The company emphasizes its manufacturing standards, which include third-party certifications such as the Clean Label Project and Informed Sport, seeking to differentiate itself in a market where quality and transparency are critical factors for consumers.
“Immunotec is no longer following industry trends, it is redefining them,” said Domenzain, suggesting that the combination of science, community and commercial results is creating a distinctive impact. The company is preparing a celebratory event in Mexico City to commemorate these milestones, closing out a year that, by its metrics, could mark a turning point in its trajectory.
Keep up to Date with Latin American VC, Startups News
